FDA Inspection
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industries – FDA Inspection, Aug 1, 2019
Record Details
This FDA Inspection record concerns Teva Pharmaceutical Industries, with an inspection on August 1, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · affb5049-f3fc-42d3-bef4-0d1b6adef04a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1101325
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Teva Pharmaceutical Industries
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 22, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 19, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 16, 2010 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Pharmaceutical Industries
- FDA Inspection 935714 - 2015-06-22
- FDA Inspection 733882 - 2011-06-19
- FDA Inspection 695835 - 2010-09-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.